Solutions that Save Lives.

Innovation that Inspires.

CGuard™ Carotid Stent System

Sustained stroke prevention in CAS(1).
Bringing patient safety through permanent embolic protection with MicroNet™(2)

Stroke is the Second Biggest Cause of Death Globally(3).

The risk of embolism with conventional carotid stenting is significant as approximately 2/3 of neurovascular events (stroke, TIA) occur after the CAS procedure takes place(4).

CGuardTM Embolic Prevention System

CGuard™ brings to the world the only carotid stent platform with patented MicroNet™ mesh technology designed to reduce stroke during and after CAS
S-icon

Safety with MicroNet

S-icon

Simplicity with SmartFit™

S-icon

Clinical Success

Our Technology
prevention_image
*Investigational device in the USA

Expert Testimonials

Hear from experienced leading physicians about the clinical and patient benefits of the CGuard EPS MicroNet™ in carotid stenting
Dr. Chris Metzger
Interventional Cardiologist

Ballad Health System CVA Heart & Vascular Institute Kingsport

TN | USA

Dr. Roberto Chiappa
Vascular Surgeon

Sandro Pertini Hospital

Rome | Italy

Fireside Chat Series with Leading Vascular Experts
TEST
TEST

TEST

Benefits

CGuard™ is designed to improve clinical outcomes and save lives by trapping and sealing thrombus and plaque against the vessel wall to prevent embolization
Minimally Invasive Procedure
Short Procedure Time
Improved clinical outcomes
SmartFit™ for ease & patient safety
image

Welcome to InspireMD

Solutions that Save Lives.
Innovation that Inspires.
InspireMD is dedicated to the development of advanced technologies such as MicroNet™, which aim to transform the future of vascular procedures to improve outcomes in revascularisation.
image
About InspireMD

News

InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists
InspireMD Announces Multiple Presentations Featuring CGuard EPS and its Novel MicroNet Mesh Covering at the 2022 VEITH Symposium
InspireMD Reports Third Quarter 2022 Financial Results and Provides Business Update

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you



    EU Authorized Representative

    Obelis s.s.
    Boulevard General Wahis 53 1030
    Brussels, Belgium
    Tel: +32 2 732 59 54
    Email: mail@obelis.net

    Israel
    Copyright © 2020 InspireMD Inc. All rights reserved.
    Site by Imaginet